- Home
- PLX vs ARBE Comparison
PLX vs ARBE Comparison
Compare PLX & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- ARBE
- Stock Information
- Founded
- PLX 1993
- ARBE 2015
- Country
- PLX United States
- ARBE Israel
- Employees
- PLX N/A
- ARBE N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- ARBE EDP Services
- Sector
- PLX Health Care
- ARBE Technology
- Exchange
- PLX Nasdaq
- ARBE Nasdaq
- Market Cap
- PLX 164.2M
- ARBE 182.6M
- IPO Year
- PLX 1998
- ARBE N/A
- Fundamental
- Price
- PLX $2.60
- ARBE $2.28
- Analyst Decision
- PLX Strong Buy
- ARBE Buy
- Analyst Count
- PLX 1
- ARBE 2
- Target Price
- PLX $15.00
- ARBE $1.75
- AVG Volume (30 Days)
- PLX 792.6K
- ARBE 5.3M
- Earning Date
- PLX 11-13-2025
- ARBE 11-26-2025
- Dividend Yield
- PLX N/A
- ARBE N/A
- EPS Growth
- PLX N/A
- ARBE N/A
- EPS
- PLX 0.08
- ARBE N/A
- Revenue
- PLX $61,948,000.00
- ARBE $536,000.00
- Revenue This Year
- PLX $14.53
- ARBE $301.82
- Revenue Next Year
- PLX $75.77
- ARBE $250.52
- P/E Ratio
- PLX $33.57
- ARBE N/A
- Revenue Growth
- PLX 62.79
- ARBE N/A
- 52 Week Low
- PLX $0.99
- ARBE $0.85
- 52 Week High
- PLX $3.10
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- PLX 82.14
- ARBE 77.87
- Support Level
- PLX $1.52
- ARBE $1.60
- Resistance Level
- PLX $2.12
- ARBE $2.20
- Average True Range (ATR)
- PLX 0.12
- ARBE 0.19
- MACD
- PLX 0.05
- ARBE 0.05
- Stochastic Oscillator
- PLX 96.79
- ARBE 97.83
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.